TY - JOUR
T1 - Persistent pain and associated risk factors in previously hospitalized COVID-19 survivors
T2 - data from an Italian cross-sectional study
AU - Castaldo, Matteo
AU - Viganò, Alessandro
AU - Giordano, Rocco
AU - Ebbesen, Brian D
AU - Guidotti, Sara
AU - Fiduccia, Alice
AU - Pruneti, Carlo
AU - DI Chiara, Michela
AU - Caroccia, Natascia
AU - Giannella, Maddalena
AU - Pillastrini, Paolo
AU - Ripamonti, Anna
AU - Fernández DE Las Peñas, César
AU - Arendt-Nielsen, Lars
PY - 2025/5/29
Y1 - 2025/5/29
N2 - BACKGROUND: The aim of this study was to investigate the prevalence and the characterization of post-COVID pain in an Italian cohort of previously hospitalized COVID-19 survivors. Furthermore, the study investigated risk factors for the presence of post-COVID pain at one year after the hospitalization.METHODS: Subjects who agreed to participate received a telephonic interview, and if meeting the inclusion criteria, they were scheduled for a clinical assessment for post-COVID pain characteristics. They also fulfilled several questionnaires: the Hospital Anxiety and Depression Scale (HADS), Pittsburgh Sleep Quality Index, Central Sensitization Inventory (CSI), pain detect, Tampa Scale of Kinesiophobia, and Pain Catastrophizing Scale.RESULTS: A sample of 246 subjects was included (36.6% women, age: 60.7± 14.5 years). Post-COVID pain prevalence was 26.2% (65 subjects), with musculoskeletal pain being the most common type (40 subjects, 16.2%). The multivariate analysis revealed that the number of post-COVID symptoms (WL=0.82, P<0.001), previous musculoskeletal pain (WL=0.82, P<0.001), HADS-D (WL=0.87, P<0.001), CSI (WL=0.84, P<0.001), obesity (WL=0.83, P=0.02), and previous neuropathic pain (WL=0.82, P=0.02) were risk factors associated with the presence of post-COVID pain. The model was able to correctly classify the 75.6% of post-COVID pain subjects and explained that 23% of the developing of post-COVID pain depends on the determined risk factors.CONCLUSIONS: The results of this study confirmed that post-COVID pain may still be present 18 months one year after the hospitalization, and several risk factors may be identified. These results underline that post-COVID pain may still be affecting COVID-19 survivors after 18 months, representing a major social health problem.
AB - BACKGROUND: The aim of this study was to investigate the prevalence and the characterization of post-COVID pain in an Italian cohort of previously hospitalized COVID-19 survivors. Furthermore, the study investigated risk factors for the presence of post-COVID pain at one year after the hospitalization.METHODS: Subjects who agreed to participate received a telephonic interview, and if meeting the inclusion criteria, they were scheduled for a clinical assessment for post-COVID pain characteristics. They also fulfilled several questionnaires: the Hospital Anxiety and Depression Scale (HADS), Pittsburgh Sleep Quality Index, Central Sensitization Inventory (CSI), pain detect, Tampa Scale of Kinesiophobia, and Pain Catastrophizing Scale.RESULTS: A sample of 246 subjects was included (36.6% women, age: 60.7± 14.5 years). Post-COVID pain prevalence was 26.2% (65 subjects), with musculoskeletal pain being the most common type (40 subjects, 16.2%). The multivariate analysis revealed that the number of post-COVID symptoms (WL=0.82, P<0.001), previous musculoskeletal pain (WL=0.82, P<0.001), HADS-D (WL=0.87, P<0.001), CSI (WL=0.84, P<0.001), obesity (WL=0.83, P=0.02), and previous neuropathic pain (WL=0.82, P=0.02) were risk factors associated with the presence of post-COVID pain. The model was able to correctly classify the 75.6% of post-COVID pain subjects and explained that 23% of the developing of post-COVID pain depends on the determined risk factors.CONCLUSIONS: The results of this study confirmed that post-COVID pain may still be present 18 months one year after the hospitalization, and several risk factors may be identified. These results underline that post-COVID pain may still be affecting COVID-19 survivors after 18 months, representing a major social health problem.
U2 - 10.23736/S0375-9393.25.18694-X
DO - 10.23736/S0375-9393.25.18694-X
M3 - Journal article
C2 - 40439708
SN - 0375-9393
JO - Minerva Anestesiologica
JF - Minerva Anestesiologica
ER -